RecruitingPhase 3ACTRN12606000088549
Preoperative intranenous N-Acetylcysteine for the prevention of renal failure in patients with renal impairment undergoing cardiac surgery
Sponsor
Prince of Wales Hospital
Enrollment
200 participants
Start Date
Aug 1, 2004
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and femalesMin Age: 18 Yearss
Plain Language Summary
Simplified for easier understanding
This study is testing whether giving a medication called N-Acetylcysteine (NAC) before heart surgery can protect the kidneys from damage. People with already-reduced kidney function are at particular risk of their kidneys getting worse during heart surgery. NAC is an antioxidant that may help shield the kidneys from injury during the operation.
You may be eligible if:
- You are 18 years or older
- You have chronic (long-term), stable reduced kidney function
- You are scheduled for heart surgery requiring a bypass machine (such as CABG or valve surgery)
- You are able to give consent
You may NOT be eligible if:
- You are a woman of childbearing age who may be pregnant, or you are pregnant or breastfeeding
- Your blood pressure is very low before surgery (below 90 mmHg)
- You have acute (sudden) kidney failure
- You are already on dialysis (haemodialysis or peritoneal dialysis)
- You took anti-inflammatory drugs (like ibuprofen) in the last 4 days
- You are allergic to acetylcysteine
- You have active severe asthma or COPD
- You have liver problems
- You have had a kidney transplant
Talk to your doctor about whether this trial might be right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients who fit into Inclusion criteria will be randomised to receive intravenous N-Acetylcestine 150mg/kg for 16 hours.
Patients who fit into Inclusion criteria will be randomised to receive intravenous N-Acetylcestine 150mg/kg for 16 hours.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12606000088549